Ulcerative colitis trials recruiting in Minnesota

All Ulcerative colitis trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
  NCT05076175 · Phase: Phase 2, Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Minnesota: Rochester
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Minnesota: Rochester
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
  NCT06095128 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Minnesota: Plymouth
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
  NCT06581328 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Plymouth
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
  NCT05442567 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Minnesota: Minneapolis, Rochester
• BOOM-IBD2 Pivotal Clinical Trial
  NCT06571669 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Minnesota: Woodbury
• Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
  NCT05987852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Minnesota: Rochester
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
  NCT07415044 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Rochester
• Microbiome-targeted Diet Therapy in Ulcerative Colitis
  NCT07520461 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• R-3750 in Patients With Mild to Moderate Ulcerative Colitis
  NCT05666960 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Minnesota: Rochester
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06029972 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Minnesota: Rochester